98 related articles for article (PubMed ID: 29669302)
1. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro.
Alyoussef A; Al-Gayyar MMH
Biomed Pharmacother; 2018 Jul; 103():362-372. PubMed ID: 29669302
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
[TBL] [Abstract][Full Text] [Related]
3. Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis
El-Far YM; Khodir AE; Noor AO; Almasri DM; Bagalagel AA; Diri RM; Kutbi HI; Al-Gayyar MMH
Redox Rep; 2020 Dec; 25(1):17-25. PubMed ID: 32172678
[No Abstract] [Full Text] [Related]
4. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.
Tayel A; Abd El Galil KH; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
Eur J Pharmacol; 2014 Apr; 728():151-60. PubMed ID: 24530413
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma.
Al-Gayyar MM; Abbas A; Hamdan AM
Biol Chem; 2016 Mar; 397(3):257-67. PubMed ID: 26733159
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM
Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of sulforaphane in mice model of skin cancer via blocking sulfatase-2.
Alyoussef A; Taha M
Exp Dermatol; 2019 Jan; 28(1):28-34. PubMed ID: 30315662
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB.
Al-Gayyar MMH; Bagalagel A; Noor AO; Almasri DM; Diri R
Biomed Pharmacother; 2019 Apr; 112():108653. PubMed ID: 30784932
[TBL] [Abstract][Full Text] [Related]
9. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.
Elewa MA; Al-Gayyar MM; Schaalan MF; Abd El Galil KH; Ebrahim MA; El-Shishtawy MM
Clin Exp Metastasis; 2015 Jun; 32(5):479-93. PubMed ID: 25999065
[TBL] [Abstract][Full Text] [Related]
10. Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo.
Yang XP; Liu L; Wang P; Ma SL
Chin Med J (Engl); 2015 May; 128(10):1384-90. PubMed ID: 25963362
[TBL] [Abstract][Full Text] [Related]
11. 5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction.
Keshari AK; Singh AK; Kumar U; Raj V; Rai A; Kumar P; Kumar D; Maity B; Nath S; Prakash A; Saha S
Drug Des Devel Ther; 2017; 11():2981-2995. PubMed ID: 29075102
[TBL] [Abstract][Full Text] [Related]
12. Activation of human Kupffer cells by thymostimulin (TP-1) to produce cytotoxicity against human hepatocellular cancer.
Balch G; Izzo F; Chiao P; Klostergaard J; Curley SA
Ann Surg Oncol; 1997 Mar; 4(2):149-55. PubMed ID: 9084852
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
[TBL] [Abstract][Full Text] [Related]
14. Induction of steroid sulfatase expression in PC-3 human prostate cancer cells by insulin-like growth factor II.
Sung CH; Im HJ; Park N; Kwon Y; Shin S; Ye DJ; Cho NH; Park YS; Choi HK; Kim D; Chun YJ
Toxicol Lett; 2013 Nov; 223(2):109-15. PubMed ID: 24055520
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects of suramin against HepG2 cells through activation of intrinsic apoptotic pathway.
Tayel A; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
J BUON; 2014; 19(4):1048-54. PubMed ID: 25536615
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma.
Alshehri MA; Alshehri MM; Albalawi NN; Al-Ghamdi MA; Al-Gayyar MMH
Oncol Lett; 2021 Feb; 21(2):173. PubMed ID: 33552290
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of echinacoside in hepatocellular carcinoma mouse model and HepG2 cells.
Ye Y; Song Y; Zhuang J; Wang G; Ni J; Xia W
J Cell Physiol; 2019 Feb; 234(2):1880-1888. PubMed ID: 30067868
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis.
Su B; Luo T; Zhu J; Fu J; Zhao X; Chen L; Zhang H; Ren Y; Yu L; Yang X; Wu M; Feng G; Li S; Chen Y; Wang H
Hepatology; 2015 Feb; 61(2):585-97. PubMed ID: 25294684
[TBL] [Abstract][Full Text] [Related]
19. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
20. Umbelliferon-α-d-glucopyranosyl-(2
Kumar V; Bhatt PC; Rahman M; Al-Abbasi FA; Anwar F; Verma A
Biomed Pharmacother; 2017 Oct; 94():834-842. PubMed ID: 28802237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
